Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125966802 | 12596680 | 2 | F | 2016 | 20160721 | 20160727 | 20160728 | EXP | US-UCBSA-2016027337 | UCB | 53.02 | YR | F | Y | 0.00000 | 20160728 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125966802 | 12596680 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 2 WEEKS(QOW) | Y | U | 901158, NDC # 20474071081 | 125160 | 400 | MG | QOW | ||||
| 125966802 | 12596680 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | Y | U | 125160 | 200 | MG | QOW | |||||
| 125966802 | 12596680 | 3 | C | ACYCLOVIR. | ACYCLOVIR | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 4 | C | CELECOXIB. | CELECOXIB | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 6 | C | ESTRADIOL. | ESTRADIOL | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 7 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 10 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 11 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 12 | C | MELOXICAM. | MELOXICAM | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 13 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 14 | C | NAPROXEN. | NAPROXEN | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 15 | C | PHENTERMINE. | PHENTERMINE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 16 | C | PREDNISONE. | PREDNISONE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 17 | C | RANITIDINE. | RANITIDINE | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 18 | C | TRAMADOL. | TRAMADOL | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 19 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 20 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | U | 0 | |||||||||
| 125966802 | 12596680 | 21 | C | Apremilast | APREMILAST | 1 | UNK | U | 0 | ||||||||||
| 125966802 | 12596680 | 22 | C | ZOSTAVAX | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125966802 | 12596680 | 1 | Psoriatic arthropathy |
| 125966802 | 12596680 | 3 | Product used for unknown indication |
| 125966802 | 12596680 | 4 | Product used for unknown indication |
| 125966802 | 12596680 | 5 | Product used for unknown indication |
| 125966802 | 12596680 | 6 | Product used for unknown indication |
| 125966802 | 12596680 | 7 | Product used for unknown indication |
| 125966802 | 12596680 | 8 | Product used for unknown indication |
| 125966802 | 12596680 | 9 | Product used for unknown indication |
| 125966802 | 12596680 | 10 | Product used for unknown indication |
| 125966802 | 12596680 | 11 | Product used for unknown indication |
| 125966802 | 12596680 | 12 | Product used for unknown indication |
| 125966802 | 12596680 | 13 | Product used for unknown indication |
| 125966802 | 12596680 | 14 | Product used for unknown indication |
| 125966802 | 12596680 | 15 | Product used for unknown indication |
| 125966802 | 12596680 | 16 | Product used for unknown indication |
| 125966802 | 12596680 | 17 | Product used for unknown indication |
| 125966802 | 12596680 | 18 | Product used for unknown indication |
| 125966802 | 12596680 | 19 | Product used for unknown indication |
| 125966802 | 12596680 | 20 | Product used for unknown indication |
| 125966802 | 12596680 | 21 | Product used for unknown indication |
| 125966802 | 12596680 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125966802 | 12596680 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125966802 | 12596680 | Drug ineffective | |
| 125966802 | 12596680 | Headache | |
| 125966802 | 12596680 | Herpes zoster |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125966802 | 12596680 | 1 | 20160209 | 201603 | 0 | |
| 125966802 | 12596680 | 2 | 201603 | 201606 | 0 | |
| 125966802 | 12596680 | 21 | 20160628 | 0 |